Andrew Alliance will be present with their own stand in MipTec 2013, the largest European conference dedicated to the science of drug discovery. MipTec offers professionals in the field of Drug Discovery and Life Sciences a platform to discuss and share knowledge about the latest scientific breakthroughs and advances in technology as well as industry standards. We can be reached at Booth B18, where – as usual – few Andrews will be available for your evaluation – including live trials of our free software, Andrew Assistant ™. We invite you in seeing live our innovative liquid handling solution, taking reproducibility to manual pipetting and saving your time for a better efficiency and competitveness. The Andrew system, awarded “new Product of the Year” at the recent international trade show SLAS 2013, is a novel liquid handler and software designed and thought for biologists, differently from the existing solutions conceived for the automation specialist.
And don’t forget that our Distributor partner in Switzerland, Sysmex Digitana, will also showcase Andrew at the adjacent ILMAC conference, in booth H1.1/C81: we will all be happy to give you a chance of discovering our novel solution, and support you towards your specific needs with our specific competence.
The mission of MipTec is to bring together scientists from all disciplines involved in drug discovery within pharmaceutical and biotech companies, academic labs and technology providers in an atmosphere, where ideas and experiences are shared and discussed. This atmosphere is created through a scientific program covering key topics and the latest breakthroughs in the diverse fields that make up drug discovery.
MipTec annually hosts leading scientists from academia and industry to explore these rapid changes in the science and technology of drug discovery, with the aim to overcome challenges for developing new medicines, advance new industry standards, and seed new opportunities.
Every year, more than 3’000 participants gather to contribute in over 100 lectures in 10 scientific tracks, 150 poster presentations and over 100 commercial exhibitors, and partake in a community of like-minded individuals to explore the opportunities and challenges at the frontiers of drug discovery.